Magsigay, Felipe A.

HRN: 29-23-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/30/2026
07/06/2026
IV
2.25g
Q8h
Sacral Ulcer
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: